Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0HFQ stock hub

LON/0HFQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HFQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HFQ

In the news

Latest news · LON/0HFQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E197.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-24.5

P25 n/aP50 n/aP75 n/a

ROIC7.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HFQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	104
Employees Change	-32%
Employees Change Percent	-23.53
Enterprise value	$1.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	US0327241065
Last refreshed	2026-05-10
Market cap	$1.5B
Price	$68.64
Price currency	USD
Rev Per Employee	1,676,057.97x
Sic	2836
Symbol	lon/0HFQ
Website	https://www.anaptysbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.67%
EV Earnings	-147.21x
EV/EBIT	41.18x
EV/EBITDA	38.72x
EV/FCF	99.33x
EV/Sales	8.41x
FCF yield	1%
Forward P/E	197.35x
P/B ratio	52.91x
P/S ratio	8.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.42%
EBITDA Margin	20.65%
FCF margin	8.36%
Gross margin	42.04%
Gross Profit	$73.3M
Gross Profit Growth Q	15,680.53%
Net Income	$-9.8M
Pretax Margin	-5.57%
Profit Margin	-5.64%
Profit Per Employee	$-94,532
ROA	7.06
Roa5y	-8.99
ROCE	14.7
ROE	-24.49
Roe5y	-71.52
ROIC	7.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	242.12%
Cagr3y	48.46%
Cagr5y	23.04%
Revenue Growth	157.02x
Revenue Growth Q	151.08x
Revenue Growth3 Y	183.58x
Revenue Growth5 Y	25.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$270.7M
Cash	$231.5M
Current Assets	$256.9M
Current Liabilities	$28.3M
Debt	$215.9M
Debt EBITDA	$5.71
Debt Equity	$7.81
Debt FCF	$14.82
Equity	$27.6M
Interest Coverage	0.6
Liabilities	$243.1M
Long Term Assets	$13.8M
Long Term Liabilities	$214.8M
Net Cash	$15.6M
Net Cash By Market Cap	$1.07
Net Cash Growth	31.98%
Net Debt EBITDA	$-0.43
Net Debt Equity	$-0.56
Net Debt FCF	$-1.07
Tangible Book Value	$27.6M
Tangible Book Value Per Share	$0.99
WACC	8.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.07
Net Working Capital	$1.5M
Quick ratio	8.94
Working Capital	$231.5M
Working Capital Turnover	$0.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	241.83%
200-day SMA	42.48
3Y total return	227.29%
50-day SMA	61.99
50-day SMA vs 200-day SMA	50over200
5Y total return	181.95%
All Time High	73.09
All Time High Change	-6.09%
All Time High Date	2026-04-13
All Time Low	11.87
All Time Low Change	478.26%
All Time Low Date	2025-02-12
ATR	5.76
Beta	0.48
Ch YTD	40.31
High	70
High52	73.09
High52 Date	2026-04-13
High52ch	-6.09%
Low	66.59
Low52	17.11
Low52 Date	2025-09-16
Low52ch	301.17%
Ma50ch	10.72%
Price vs 200-day SMA	61.59%
RSI	55.73
RSI Monthly	75.72
RSI Weekly	64.18
Sharpe ratio	1.73x
Sortino ratio	3
Total Return	-1.33%
Tr YTD	40.31
Tr1m	10.38%
Tr1w	3.64%
Tr3m	35.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$35.6M
Operating margin	20.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,263,009%
Shares Insiders	2.93%
Shares Institutions	65.62%
Shares Qo Q	8.01%
Shares Yo Y	1.33%
Short Ratio	6.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.2M
Average Volume	1,077.05x
Bv Per Share	0.99
CAPEX	$-64,641
Ch1m	10.38
Ch1w	3.64
Ch1y	241.8
Ch3m	35.36
Ch3y	227.3
Ch5y	181.9
Ch6m	79.14
Change	10.24%
Change From Open	-1.94
Close	62.27
Days Gap	12.42
Depreciation Amortization	410,034.3
Dollar Volume	7,619
Earnings Date	2026-05-15
EBIT	$35.6M
EBITDA	$36M
EPS	$-0.34
F Score	6
FCF	$14.6M
FCF EV Yield	1.01x
Financing CF	-98,531,459
Fiscal Year End	December
Founded	2,005
Income Tax	$121,852
Investing CF	169,427,776
Is Primary Listing	0
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	49.1
Ma150ch	39.78%
Ma20	63.35
Ma20ch	8.35%
Net CF	85,531,188
Next Earnings Date	2026-05-15
Open	70
P FCF Ratio	100.4
P OCF Ratio	99.95
Position In Range	60.17
Ppne	10,187,775.9
Price Date	2026-05-08
Price EBITDA	$40.63
Ptbv Ratio	52.91
Relative Volume	0.1x
Revenue	174,310,029x
SBC By Revenue	15.38x
Share Based Comp	26,801,496
Tax By Revenue	0.07x
Tr6m	79.14%
Volume	111
Z Score	0.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HFQ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HFQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HFQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+65.6%

Share of float held by funds and institutions

Insider ownership

+2.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HFQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.7

Neutral momentum band

Price vs 200-day MA

+61.6%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

1.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HFQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HFQ stock rating?

lon/0HFQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HFQ analysis?

The full report lives at /stocks/lon/0HFQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HFQ?

The latest report frames lon/0HFQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HFQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.